Abstract
Objective:
To study the clinical and molecular biological characteristics of infant acute leukemia (IAL).
Methods:
R and/or G banding technique was used for analysis of karyotype. DNA blotting for HRX gene rearrangement, and polymerase chain reaction (PCR) and reverse transcriptase PCR (RT-PCR) for fusion gene detection.
Results:
Twenty cases of IAL were detected. HRX gene rearrangement was found in 10 cases, including HRX/AF-4 fusion gene in 5, HRX/AF-9 fusion in 2, and HRX/ENL fusion in 1, HRX self-fusion mediated by alu-repeat homologous recombination and HRX/EEN fusion each in one (HRX/EEN is a novel fusion gene reported for the first time).
Conclusion:
High frequency of HRX gene rearrangement occurred in IAL, which is characterised by a massive leukemia cell burden and 11q23 translocation, forming fusion genes, especially HRX/AF-4 (about 50%). The results are of important significance in guiding clinical treatment and approaching the etiology of IAL.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Blotting, Southern
-
Child, Preschool
-
Chromosome Aberrations
-
DNA, Neoplasm / genetics
-
DNA, Neoplasm / metabolism
-
DNA-Binding Proteins / genetics
-
Female
-
Histone-Lysine N-Methyltransferase
-
Humans
-
Immunophenotyping
-
Infant
-
Karyotyping
-
Leukemia / genetics*
-
Leukemia / immunology
-
Leukemia / mortality
-
Leukemia, Monocytic, Acute / genetics
-
Leukemia, Monocytic, Acute / immunology
-
Leukemia, Monocytic, Acute / mortality
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / immunology
-
Leukemia, Myeloid, Acute / mortality
-
Male
-
Myeloid-Lymphoid Leukemia Protein
-
Oncogene Proteins, Fusion / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
-
Proto-Oncogenes*
-
RNA, Neoplasm / genetics
-
RNA, Neoplasm / metabolism
-
Reverse Transcriptase Polymerase Chain Reaction
-
Survival Rate
-
Time Factors
-
Transcription Factors*
Substances
-
DNA, Neoplasm
-
DNA-Binding Proteins
-
KMT2A protein, human
-
Oncogene Proteins, Fusion
-
RNA, Neoplasm
-
Transcription Factors
-
Myeloid-Lymphoid Leukemia Protein
-
Histone-Lysine N-Methyltransferase